RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Innocan Pharma Stock

Innocan Pharma Market capitalization 2024

Innocan Pharma Market capitalization

40.59 M USD

Ticker

INNO.CN

ISIN

CA45783P1027

WKN

A2PSPW

In 2024, Innocan Pharma's market cap stood at 40.59 M USD, a -31.47% increase from the 59.23 M USD market cap in the previous year.

The Innocan Pharma Market capitalization history

YEARMarket Capitalization (undefined USD)
202340.59
202291.96
2021103.04
202022.98
201923.04
2018-
2017-

Innocan Pharma Aktienanalyse

What does Innocan Pharma do?

Innocan Pharma ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Market capitalization Details

Exploring Innocan Pharma's Market Capitalization

Innocan Pharma's market capitalization represents the total dollar market value of the company’s outstanding shares of stock. It is calculated by multiplying the company's shares outstanding by the current market price of one share. This metric is a vital indicator of a company’s size, strength, and overall market value.

Year-to-Year Comparison

A yearly comparison of Innocan Pharma's market capitalization provides investors and analysts insights into its growth and valuation trends. An increase signifies market confidence and business expansion, while a decrease may point towards declining market value or business contractions.

Impact on Investments

Innocan Pharma's market capitalization plays a pivotal role in investment decisions. It aids investors in assessing the company's risk and return profiles. Larger companies are often considered more stable but may offer lower growth potential, while smaller companies might offer significant growth prospects but come with higher risk.

Interpreting Market Capitalization Fluctuations

Variations in Innocan Pharma’s market capitalization can be attributed to several factors, including changes in stock price, outstanding shares, and market sentiment. Understanding these fluctuations helps investors evaluate the company's current standing and future potential in the competitive landscape.

Frequently Asked Questions about Innocan Pharma stock

What is the current Innocan Pharma market capitalization?

The current market capitalization of Innocan Pharma is 40.59 M USD.

What is market capitalization?

The market capitalization (German: Marktkapitalisierung, English: market capitalization, abbreviated as market cap, also known as stock exchange capitalization or market value) is the calculated total value of all shares of a publicly traded company like Innocan Pharma.

How has the market capitalization of Innocan Pharma developed in recent years?

The market capitalization of Innocan Pharma has increased/decreased by -31.47% compared to the previous year.

What does market capitalization mean for investors?

The market capitalization of a company reflects the current market consensus on the value of the equity of a publicly traded company.

Why is market capitalization an important indicator for investors?

The market capitalization of a company reflects the current market consensus on the value of a publicly traded company's equity. It is determined by the supply and demand for the company's shares. Market capitalization is thus significantly influenced by expectations in the stock market regarding the future earnings power of the company, and as such, it can undergo significant fluctuations.

Why does the market capitalization fluctuate?

The market capitalization fluctuates along with the stock price, as the market capitalization is calculated based on the current price and the number of outstanding shares.

What role does market capitalization play in the valuation of Innocan Pharma?

In order to compare the value of companies, it is helpful to consider not only the market capitalization but also the net debt of a company. A potential buyer of the entire company would also acquire the debts of the company. The enterprise value is the total value of a company or a stock corporation. The net financial indebtedness of the company is added to the market capitalization.

Does the market capitalization influence the performance of Innocan Pharma?

There is no verifiable long-term evidence or study that stocks with a specific market capitalization (whether Mega/Large/Mid/Small Cap) would consistently yield significantly higher returns than others. There are occasional small studies (few stocks, short investment period) suggesting that certain classes may perform better or have higher risk, but none of them are 1. conclusive (cause-effect relationship is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).

Does the market capitalization of Innocan Pharma have an influence on indices?

Some stock indices use market capitalization as index weighting. Stocks with a higher market capitalization are also weighted higher in the index. This is in contrast to equally weighted indices (all stocks have the same weighting) and free float weighted indices (market capitalization weighting, but only with the number of shares in free float).

How much dividend does Innocan Pharma pay?

Over the past 12 months, Innocan Pharma paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Innocan Pharma is expected to pay a dividend of 0 USD.

What is the dividend yield of Innocan Pharma?

The current dividend yield of Innocan Pharma is .

When does Innocan Pharma pay dividends?

Innocan Pharma pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Innocan Pharma?

Innocan Pharma paid dividends every year for the past 0 years.

What is the dividend of Innocan Pharma?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Innocan Pharma located?

Innocan Pharma is assigned to the 'Health' sector.

Wann musste ich die Aktien von Innocan Pharma kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Innocan Pharma from 11/1/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 11/1/2024.

When did Innocan Pharma pay the last dividend?

The last dividend was paid out on 11/1/2024.

What was the dividend of Innocan Pharma in the year 2023?

In the year 2023, Innocan Pharma distributed 0 USD as dividends.

In which currency does Innocan Pharma pay out the dividend?

The dividends of Innocan Pharma are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Innocan Pharma

Our stock analysis for Innocan Pharma Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Innocan Pharma Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.